Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Professor Michael Dustin on his election as a member of the European Molecular Biology Organisation (EMBO).

Professor Dustin was one of 65 outstanding life scientists to be elected to its membership, joining a group of more than 1700 of the best researchers in Europe and around the world.

Professor Michael Dustin joins Professor Fiona Powrie and Sir Marc Feldman as EMBO members from the Kennedy Institute of Rheumatology.

EMBO Director Maria Leptin said:

“Election to the EMBO Membership is recognition of research excellence, and I am pleased to welcome so many great scientists to our organisation.”

She continues: “We received more nominations than ever before during this election cycle, which pays tribute to the strength and diversity of the European life sciences. Drawing on our new members’ expertise and insight will be invaluable in helping EMBO to deliver and strengthen its programmes and activities in the years to come.”

Professor Dustin exclaimed:

“It’s an honour to be elected a member of EMBO only a few years after arriving here in the UK. I look forward to contributing to EMBO’s mission in years to come.”

EMBO Members are actively involved in the execution of the organisation’s initiatives by evaluating applications for EMBO funding and by serving on EMBO Council, Committees and Editorial Boards.

An online directory with all existing and new EMBO Members is available at people.embo.org.

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).